Epidiolex and Aristocort drug interactions - a phase IV clinical study of FDA data
Summary:
There is no or few drug interactions reported by people who take Epidiolex and Aristocort together.
The phase IV clinical study analyzes what interactions people have when they take Epidiolex and Aristocort. It is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Epidiolex?
Epidiolex has active ingredients of cannabidiol. Currently, eHealthMe is studying from 17,240 Epidiolex users.
What is Aristocort?
Aristocort has active ingredients of triamcinolone. Currently, eHealthMe is studying from 482 Aristocort users.
Do you take Epidiolex and Aristocort?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Drug side effects by duration, gender and age:
- Epidiolex side effects (17,240 reports)
- Aristocort side effects (482 reports)
How the study uses the data?
The study uses data from the FDA. It is based on cannabidiol and triamcinolone (the active ingredients of Epidiolex and Aristocort, respectively), and Epidiolex and Aristocort (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Epidiolex and Aristocort.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Lamictal and Premphase 14/14 drug interaction - 6 seconds ago
- Alinia and Ciclopirox drug interaction - 18 seconds ago
- Indapamide and Cardiac Murmur - 19 seconds ago
- Accolate and Speech Impairment (Adult) - 40 seconds ago
- Tramadol Hydrochloride and Buspirone Hydrochloride drug interaction - 48 seconds ago
- Bendamustine Hydrochloride and Multiple Myeloma - 59 seconds ago
- Gemcitabine and Bradycardia - a minute ago
- Pravachol and Amidate drug interaction - a minute ago
- Tagrisso and Loperamide Hydrochloride drug interaction - a minute ago
- Hydroxyzine Hydrochloride and Bronchospasm - a minute ago